Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran

[1]  W. Sadoh,et al.  Comparison of adverse events following pentavalent and diphtheria‐tetanus‐pertussis vaccines among Nigerian children , 2018, Pharmacoepidemiology and drug safety.

[2]  M. Karami,et al.  Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran , 2017, BMC Immunology.

[3]  Jing-xin Li,et al.  The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months , 2017, Expert review of vaccines.

[4]  S. Lalwani,et al.  Immunogenicity and safety of a liquid hexavalent vaccine in Indian infants , 2017, Indian Pediatrics.

[5]  M. Karami,et al.  Adverse Effects of Influenza Vaccination among Healthcare Staff in Shiraz in 2014, Iran , 2016 .

[6]  A. Heidarzadeh,et al.  Comparison of complications of pentavalent and DTP vaccination in infants aged 2-6 months in Anzali, Iran , 2016 .

[7]  S. Tafuri,et al.  Adverse events following immunization: is this time for the use of WHO causality assessment? , 2015, Expert review of vaccines.

[8]  A. Rodríguez-Morales,et al.  The 2014 FIFA World Cup: communicable disease risks and advice for visitors to Brazil--a review from the Latin American Society for Travel Medicine (SLAMVI). , 2014, Travel medicine and infectious disease.

[9]  H. Clothier,et al.  Active surveillance for adverse events following immunization , 2014, Expert review of vaccines.

[10]  L. Moulton,et al.  Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. , 2013, Vaccine.

[11]  Yu Hu,et al.  Surveillance for Adverse Events following Immunization from 2008 to 2011 in Zhejiang Province, China , 2012, Clinical and Vaccine Immunology.

[12]  Leonard Leibovici,et al.  Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). , 2012, The Cochrane database of systematic reviews.

[13]  M. Manglani,et al.  Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process. , 2012, Vaccine.

[14]  A. Schuchat,et al.  Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. , 2011, MMWR supplements.

[15]  R. Ghorbani,et al.  The incidence of complications of vaccination in children and infants of Semnan, Iran. , 2010 .

[16]  O. Lunacsek,et al.  Combination vaccine use and vaccination quality in a managed care population. , 2007, The American journal of managed care.

[17]  R. von Kries,et al.  The Use of Combination Vaccines Has Improved Timeliness of Vaccination in Children , 2006, The Pediatric infectious disease journal.

[18]  Mohammad Reza Aflatoonian,et al.  EXPERIENCE OF A POPULATION- BASED STUDY ON, NEEDS AND HEALTH STATUS OF AFFECTED PEOPLE IN BARN EARTH QUAKE , 2005 .

[19]  S. Gatchalian,et al.  Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[20]  M. Decker.  Principles of pediatric combination vaccines and practical issues related to use in clinical practice , 2001, The Pediatric infectious disease journal.

[21]  C P Farrington,et al.  Epidemiology of transmissible diseases after elimination. , 2000, American journal of epidemiology.

[22]  R. Insel.  Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components a , 1995, Annals of the New York Academy of Sciences.

[23]  L. Leibovici,et al.  Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). , 2012, The Cochrane database of systematic reviews.

[24]  J. Iskander,et al.  Chapter 21: Surveillance for Adverse Events Following Immunization , 2008 .

[25]  Global Programme for Vaccines and Immunization (GPV). The WHO position paper on Haemophilus influenzae type b conjugate vaccines. , 1998, Releve epidemiologique hebdomadaire.

[26]  E. Shapiro,et al.  The epidemiology and prevention of disease caused by Haemophilus influenzae type b. , 1991, Epidemiologic reviews.